The association of statin use and statin type and cognitive performance: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study

Clinical Cardiology

Volumn 33, Issue 5, 2010, Pages 280-288

  Glasser, Stephen P ^a   Wadley, Virginia ^c   Judd, Suzanne ^a   Kana, Bhumika ^a   Prince, Valerie ^c   Jenny, Nancy ^f   Kissela, Brett ^d   Safford, Monika ^b   Prineas, Ronald ^e   Howard, George ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c SAMFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATION; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; POPULATION BASED CASE CONTROL STUDY; RACE DIFFERENCE; SCORING SYSTEM; SIX ITEM SCREENER; STROKE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DATABASES AS TOPIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; STROKE; UNITED STATES;

EID: 77953163428     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20758     Document Type: Article

References (26)

1. Elias MF, Sullivan LM, D'Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004;35:404-409.
2. Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005;24:42-50.
3. Prencipe M, Santini M, Casini AR, et al. Prevalence of nondementing cognitive disturbances and their association with vascular risk factors in an elderly population. J Neurol. 2003;250:907-912.
4. Saxby BK, Harrington F, McKeith IG, et al. Effects of hypertension on attention, memory, and executive function in older adults. Health Psychol. 2003;22:587-591.
5. King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy. 2003;23:1663-1667.
6. Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy. 2001;21:767-769.
7. Harrison RW, Ashton CH. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. Br J Clin Pharmacol. 1994;37:231-236.
8. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163:197-203.
9. Howard VJ, Cushman M, Pulley L, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
11. Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40:771-781.
12. Wilber ST, Carpenter CR, Hustey FM. The Six-Item Screener to detect cognitive impairment in older emergency department patients. Acad Emerg Med. 2008;15:613-616.
13. Howard G, Wadley VG, Unverzagt FW, et al. Stroke risk factors are predictive of cognitive decline in the absence of clinically diagnosed incident stroke (abstract). Stroke. 2008;39.
14. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227-234.
15. Pullicino PM, Wadley VG, McClure LA, et al. Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail. 2008;14:290-295.
16. Wadley VG, Unverzagt FW, McGuire LC, et al. Incidence of impaired cognitive screening status is higher than average in the Stroke Belt: the Reasons for Geographic and Racial Differences in Stroke Study. Under review.
17. Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739-747.
18. Manly JJ, Tang MX, Schupf N, et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63:494-506.
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
20. Gengo F, Cwudzinski D, Kinkel P, et al. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance. Clin Cardiol. 1995;18:209-214.
21. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-1630.
22. Szwast SJ, Hendrie HC, Lane KA, et al. Association of statin use with cognitive decline in elderly African Americans. Neurology. 2007;69:1873-1880.
23. Peters JT, Garwood CL, Lepczyk M. Behavioral changes with paranoia in an elderly woman taking atorvastatin. Am J Geriatr Pharmacother. 2008;6:28-32.
24. Carlsson CM, Gleason CE, Hess TM, et al. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middleaged adults at risk for Alzheimer's disease. J Alzheimers Dis. 2008;13:187-197.
25. Caballero J, Nahata M. Do statins slow down Alzheimer's disease? A review. J Clin Pharm Ther. 2004;29:209-213.
26. Kuller LH. Statins and dementia. Curr Atheroscler Rep. 2007;9:154-161.